ED May Herald Coronary Heart Disease
ANAHEIM, Calif.—Erectile dysfunction (ED) may predict future coronary heart disease (CHD).
ANAHEIM, Calif.—Erectile dysfunction (ED) may predict future coronary heart disease (CHD).
VIENNA—Erectile dysfunction (ED) may be a common adverse effect of thalidomide used to treat hematologic diseases, according to a study presented here at the 12th Congress of the European Hematology Association.
BERLIN—Two recent French studies have characterized the effect of prostate brachytherapy on erectile and ejaculatory function.
Vascular disease may explain the previously established link be-tween smoking and erectile dysfunction (ED), a Finnish study suggests. Additionally, ED may be a silent vascular disease in ex-smokers.
A study of men in a rural community in Brazil revealed an extremely low prevalence of erectile dysfunction (ED).
It’s increasingly clear that erectile dysfunction (ED) is strongly linked to a range of underlying ailments including systemic vascular disease, diabetes, and obesity. These disorders, in turn, are associated with diet, exercise, and other lifestyle and emotional factors.
Regular use of sildenafil lowers BP in patients with hypertension, according to researchers in the United Kingdom.
Overactive bladder (OAB) symptoms in middle-aged or older men are associated with an increased risk of erectile dysfunction (ED).
The first human study using gene transfer to treat erectile dysfunction (ED) shows promising results, according to researchers.
Early use of phosphodiesterase inhibitors (PDEIs) following brachytherapy is associated with improved erectile function compared with late use of the drugs.